Create an Account

Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy

Meeting report with presentation slides, videos and online CME of the EBAC-accredited symposium held at ESC Congress 2023, Amsterdam, The Netherlands.

Episodes 1-3 of 3

  • Treating hyperkalemia in patients with HFTreating hyperkalemia in patients with HF
    Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy
    Treating hyperkalemia in patients with HF
    • Mikhail Kosiborod, MD
      Mikhail Kosiborod, MD

      Mikhail Kosiborod, MD

  • Prescribing and monitoring novel potassium binders for optimizing RAASi therapy in HFPrescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF
    Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy
    Prescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF
    • Aaron Wong, MD
      Aaron Wong, MD

      Aaron Wong, MD

  • The key role of RAASi therapy in patients with HFThe key role of RAASi therapy in patients with HF
    Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy
    The key role of RAASi therapy in patients with HF
    • Shelley Zieroth, MD
      Shelley Zieroth, MD

      Shelley Zieroth, MD

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.